Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chia-Che Wu

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Arthritis and Rheumatism|January 31, 2009
In vitro stage-specific chondrogenesis of mesenchymal stem cells committed to chondrocytesWei-Hong Chen, Ming-Tang Lai, Alexander T H Wu, et al.
Cells|June 10, 2023
Inhibiting WEE1 Augments the Antitumor Efficacy of Cisplatin in Urothelial Carcinoma by Enhancing the DNA Damage ProcessYu-Li Su, Ling-Yi Xiao, Shih-Yu Huang, et al.
Cancer Medicine|December 18, 2016
Survival prognostic factors for metachronous second primary head and neck squamous cell carcinomaJin-Hua Chen, Yu-Chun Yen, Tsung-Ming Chen, et al.
Frontiers in Oncology|December 17, 2020
Safety and Efficacy of Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma and End-Stage Renal Disease: Experiences From Real-World PracticeMing-Chun Kuo, Po-Jung Su, Chun-Chieh Huang, et al.
World Journal of Gastroenterology|September 18, 2015
Trousseau's syndrome in a patient with advanced stage gastric cancerTai-Long Chien, Kung-Ming Rau, Wen-Jung Chung, et al.
Medicine|November 13, 2015
Dementia Risk in Irradiated Patients With Head and Neck CancerJin-Hua Chen, Yu-Chun Yen, Shing-Hwa Liu, et al.
Talanta|October 12, 2021
Peptide-based electrochemical sensor with nanogold enhancement for detecting rheumatoid arthritisChing-Yu Lin, Uyen Thi Nhat Nguyen, Han-Yun Hsieh, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 19, 2022
First-line Immune Checkpoint Inhibitor Versus Immune Checkpoint Inhibitor With Chemotherapy for Cisplatin-ineligible Metastatic Urothelial Carcinoma: Evidence From a Real-world, Multicenter AnalysisChang-Ting Lin, Po-Jung Su, Shih-Yu Huang, et al.
Oncology|December 4, 2019
Comparative Study of the Safety and Efficacy of First-Line Cisplatin and Carboplatin Chemotherapy in Elderly Patients with Metastatic Urothelial CarcinomaShih-Yu Huang, Chia-Che Wu, Meng-Che Hsieh, et al.
Cancer Medicine|February 9, 2024
The impact of body mass index on survival endpoints among patients with metastatic urothelial carcinoma undergoing treatment with immune checkpoint inhibitors: A real-world multicenter analysisShih-Yu Huang, Po-Jung Su, Chang-Ting Lin, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Arthritis and Rheumatism|January 31, 2009
In vitro stage-specific chondrogenesis of mesenchymal stem cells committed to chondrocytesWei-Hong Chen, Ming-Tang Lai, Alexander T H Wu, et al.
Cells|June 10, 2023
Inhibiting WEE1 Augments the Antitumor Efficacy of Cisplatin in Urothelial Carcinoma by Enhancing the DNA Damage ProcessYu-Li Su, Ling-Yi Xiao, Shih-Yu Huang, et al.
Cancer Medicine|December 18, 2016
Survival prognostic factors for metachronous second primary head and neck squamous cell carcinomaJin-Hua Chen, Yu-Chun Yen, Tsung-Ming Chen, et al.
Frontiers in Oncology|December 17, 2020
Safety and Efficacy of Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma and End-Stage Renal Disease: Experiences From Real-World PracticeMing-Chun Kuo, Po-Jung Su, Chun-Chieh Huang, et al.
World Journal of Gastroenterology|September 18, 2015
Trousseau's syndrome in a patient with advanced stage gastric cancerTai-Long Chien, Kung-Ming Rau, Wen-Jung Chung, et al.
Medicine|November 13, 2015
Dementia Risk in Irradiated Patients With Head and Neck CancerJin-Hua Chen, Yu-Chun Yen, Shing-Hwa Liu, et al.
Talanta|October 12, 2021
Peptide-based electrochemical sensor with nanogold enhancement for detecting rheumatoid arthritisChing-Yu Lin, Uyen Thi Nhat Nguyen, Han-Yun Hsieh, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 19, 2022
First-line Immune Checkpoint Inhibitor Versus Immune Checkpoint Inhibitor With Chemotherapy for Cisplatin-ineligible Metastatic Urothelial Carcinoma: Evidence From a Real-world, Multicenter AnalysisChang-Ting Lin, Po-Jung Su, Shih-Yu Huang, et al.
Oncology|December 4, 2019
Comparative Study of the Safety and Efficacy of First-Line Cisplatin and Carboplatin Chemotherapy in Elderly Patients with Metastatic Urothelial CarcinomaShih-Yu Huang, Chia-Che Wu, Meng-Che Hsieh, et al.
Cancer Medicine|February 9, 2024
The impact of body mass index on survival endpoints among patients with metastatic urothelial carcinoma undergoing treatment with immune checkpoint inhibitors: A real-world multicenter analysisShih-Yu Huang, Po-Jung Su, Chang-Ting Lin, et al.
Pageof 6